Viscosol Treatment Improves Lipid Metabolism in Diabetic Mice
Author Information
Author(s): Raza Idrees, Sohail Aamir, Muneer Hamza, Fayyaz Hajra, Uddin Zia, Almars Amany I., Aggad Waheeb S., Almohaimeed Hailah M., Ullah Imran
Primary Institution: Quaid-i-Azam University, Islamabad, Pakistan
Hypothesis
Can Viscosol treatment improve insulin-mediated regulation of dyslipidemia and hepatic steatosis in a type-2 diabetic mice model?
Conclusion
Viscosol treatment effectively reduces dyslipidemia and improves liver health in type-2 diabetic mice by targeting PTP1B.
Supporting Evidence
- Viscosol treatment led to a significant reduction in LDL, VLDL, TC, and TG levels in the serum of diabetic mice.
- Histological analysis showed retrieval of normal morphology in adipocytes and hepatocytes after Viscosol treatment.
- Real-time PCR results indicated enhanced expression of insulin signaling markers in treated mice.
- Viscosol upregulated genes involved in lipoprotein clearance and fatty acid uptake in adipocytes.
Takeaway
This study shows that a natural compound called Viscosol can help mice with diabetes by improving their fat and sugar levels in the blood.
Methodology
The study used a high-fat diet and low-dose streptozotocin-induced diabetic mice model to evaluate the effects of Viscosol on lipid metabolism and insulin signaling.
Potential Biases
Potential bias in the selection of animal models and the specific focus on gene expression without broader metabolic assessments.
Limitations
The study primarily focused on gene expression without evaluating protein levels or long-term effects of Viscosol treatment.
Participant Demographics
Adult male C57BL/6 mice, average weight 25–40 g, average age 8–12 weeks.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website